What does a Thyroid Imaging Reporting and Data System (TI‑RADS) 4 result on a thyroid ultrasound mean?

TI-RADS 4 Indicates a Moderately Suspicious Thyroid Nodule Requiring Risk-Based Evaluation

A TI-RADS 4 thyroid nodule means your nodule has moderately suspicious ultrasound features that place it at intermediate risk for malignancy, typically requiring fine-needle aspiration (FNA) biopsy if it meets specific size criteria. 1

Understanding the TI-RADS Classification System

The Thyroid Imaging Reporting and Data System (TI-RADS) is a standardized risk stratification tool that assigns points based on five ultrasound features of thyroid nodules. The system categorizes nodules from TR1 (benign) to TR5 (highly suspicious), with the primary goal of standardizing terminology and minimizing unnecessary biopsies. 1, 2

TI-RADS 4 specifically indicates your nodule has features that warrant concern but are not definitively malignant-appearing. This category is further subdivided in some systems:

• TI-RADS 4a: One suspicious feature (approximately 5% malignancy risk) 3
• TI-RADS 4b: Two suspicious features (approximately 30% malignancy risk) 3
• TI-RADS 4c: Three or four suspicious features (approximately 76% malignancy risk) 3

What This Means for Malignancy Risk

The actual malignancy rate for TI-RADS 4 nodules ranges from 14% to 58% depending on the specific subcategory and study population. 4, 5, 6 This is substantially lower than TI-RADS 5 nodules (which carry 52-100% malignancy risk) but significantly higher than TI-RADS 3 nodules (approximately 1-13% malignancy risk). 4, 5, 3

Important context: Even when TI-RADS 4 nodules prove to be malignant, they are typically papillary thyroid carcinomas with excellent prognosis—10-year survival rates approach 99%. 7 The overall rate of thyroid cancer in patients with thyroid nodules is only 3-5%. 1

Clinical Management Algorithm

Size-Based Biopsy Recommendations

The decision to perform FNA depends critically on nodule size:

• Nodules ≥1.5 cm: FNA is generally recommended for TI-RADS 4 nodules at this size threshold 2
• Nodules 1.0-1.5 cm: Consider FNA based on additional risk factors 1
• Nodules <1 cm: Generally surveillance is recommended, even for high-risk appearing nodules, unless specific high-risk features are present 1

Critical exceptions requiring FNA regardless of size:

• Subcapsular location (near the thyroid capsule)
• Suspicious cervical lymphadenopathy present
• History of head/neck radiation exposure
• Family history of thyroid cancer
• Clinical symptoms suggesting invasion 8, 9

If FNA is Performed

When cytology is obtained, results typically fall into these categories:

• Benign: Surveillance with repeat ultrasound
• Follicular neoplasm or suspicious: Surgical consultation required
• Malignant or suspicious for malignancy: Surgical evaluation and staging 1, 8

Important limitation: Cytology may identify papillary thyroid carcinoma but rarely can specify the cancer subtype, which affects long-term prognosis. 1 Molecular testing may be added to refine risk assessment, with high-risk mutations being more common in TI-RADS 5 than TI-RADS 4 nodules. 4

Key Pitfalls to Avoid

1. Don't assume size alone determines malignancy risk: A 9mm nodule with multiple suspicious features carries similar malignancy risk to a 35mm nodule with the same features. 1

2. Don't biopsy all TI-RADS 4 nodules reflexively: For nodules <1 cm without high-risk clinical features, surveillance is appropriate even if ultrasound appears suspicious. 1

3. Don't equate "suspicious" with "requires immediate surgery": Most small thyroid cancers are indolent, and active surveillance may be appropriate for select patients even after cancer diagnosis. 1

4. Recognize the complexity of "small" nodules: Current guidelines have inherent contradictions—TI-RADS may not recommend biopsy for a 9mm nodule, yet if biopsied and malignant, treatment guidelines recommend surgery. This creates clinical uncertainty that requires individualized discussion. 1

What Happens Next

Your physician should:

• Measure the exact nodule dimensions
• Assess for suspicious lymph nodes on ultrasound
• Review your personal risk factors (radiation history, family history, symptoms)
• Determine if FNA is indicated based on size and risk factors
• If FNA is not indicated, establish a surveillance schedule with repeat ultrasound (typically 12-24 months)

The positive predictive value of TI-RADS 4 for malignancy is approximately 40-84%, meaning that even in this "moderately suspicious" category, many nodules prove benign. 5, 6 The system's strength lies in its high negative predictive value (94%), effectively identifying nodules that can safely be monitored rather than biopsied. 5